
|Articles|December 1, 2002
- Volume 0 0
Heavy Periods Affect Productivity and Income
Advertisement
Women with heavy menstrual periods lose an estimated 3.6 workweeks per year and an estimated $1692 annually in wages, compared with the general female workforce, according to data from the 1999 National Health Interview Survey. In addition, a lower proportion of women with heavy periods reported that they were currently employed (63% vs 74%), and that their health was excellent or very good (approximately 50% vs 70%), compared with women with low or normal periods. The findings were reported in Obstetrics & Gynecology.
Articles in this issue
almost 24 years ago
Smoking Cessation: Not Just Blowing Smokealmost 24 years ago
Nurse Diversion in Health Facilities?Part Ialmost 24 years ago
The Dosage Was Too High, No Matter Where the Rx Was Filledalmost 24 years ago
Nonestrogen Treatments for Hot Flashesalmost 24 years ago
The Goodness in Beeralmost 24 years ago
Recommendations on Use of Hormone Replacement Therapyalmost 24 years ago
Musts for the Medicine Cabinetalmost 24 years ago
Routine Osteoporosis Screening RecommendedAdvertisement
Related to this article

BRUIN CLL-313 showed significantly longer progression-free survival vs bendamustine plus rituximab, bringing a noncovalent BTK inhibitor to first-line care.

A behavioral walking program matched supervised aerobic training for improving asthma control in a randomized trial of physically inactive adults.

Phase 2b data from EASD 2026 show the amylin-incretin combination also cut HbA1c by up to 2.9% in adults with obesity or overweight and type 2 diabetes.

American Pharmacists Month kicked off on October 1, honoring more than 700,000 pharmacy professionals and 250 years of caring for America's communities.

fMRI data show cagrilintide-semaglutide altered brain responses to high-calorie food cues; REIMAGINE analyses point to ectopic fat and bone effects.

Decades after cisplatin's approval, platinum-based chemotherapy continues to anchor treatment regimens across tumor types, new research finds.

A pharmacist-led collaborative drug therapy management program at NYC Health + Hospitals/Bellevue reported high patient satisfaction, and every surveyed patient said they felt respected and supported by their pharmacist.
Advertisement
Advertisement
Trending on Pharmacy Times
1
EloraTZP Delivers Up to 23.3% Weight Loss in Adults With Obesity and T2D
2
Why Lp(a) Testing Lagged Behind LDL Cholesterol Screening
3
Pharmacists Key to Lp(a) Counseling and Lipid Optimization
4
What the 2025-2030 Dietary Guidelines Mean for Heart Health
5

